Supplementary Table 1.
Baseline Characteristics of Included Studies With Hyperlipasemia in Coronavirus Disease 2019
| First author | Type of study | Region | Sample size | Male patients, n | Definition of hyperlipasemia (serum lipase levels, U/L) |
|---|---|---|---|---|---|
| McNabb-Baltar7 | Retrospective multicenter cohort study | United States | 71 patients with COVID-19 | 32 | >60 |
| Barlass8 | Retrospective cohort single-center study | United States | 1003 patients with COVID-19; 83 with available lipase levels | 11 | >3 × ULN; >156 |
| Liu3 | Retrospective observational multicenter study | China | 121 patients with COVID-19 | 75 | >78 |
| Aghemo9 | Retrospective observational single-center study | Italy | 292 patients with COVID-19; lipase levels available in 249 patients | 199 | >68 |
| Wang6 | Retrospective observational single-center study | China | 52 patients with COVID-19 | 24 | >70 |
| Bruno10 | Retrospective observational single-center study | Italy | 70 patients with COVID-19 | Not reported | >393 |
| Pezzilli11 | Prospective observational single-center study | Italy | 110 patients with COVID-19 | 69 | >300 |
ULN, upper limit of normal.